Our head and neck surgery team at Lister Hospital provides comprehensive care for both benign and malignant conditions affecting the mouth, throat, larynx (voice box), salivary glands, and neck. We deliver expert surgical treatment for a wide range of conditions, including cancers of the oral cavity, oropharynx, larynx, and salivary glands, as well as non-cancerous tumours and structural abnormalities.
We adopt a robust multidisciplinary approach for managing head and neck cancers, working closely with colleagues in oncology, radiology, pathology, speech and language therapy, dietetics, and palliative care. Every patient benefits from a tailored treatment plan designed and agreed upon at specialist head and neck cancer MDT meetings, ensuring high-quality, coordinated care.
Advanced surgical technology is routinely used to improve patient outcomes and minimise complications. This includes nerve monitoring during major neck procedures to protect vital structures such as the facial and recurrent laryngeal nerves, which are crucial for facial expression and voice.
Our team is experienced in Transoral Robotic Surgery (TORS), a minimally invasive technique used primarily for selected tumours of the oropharynx and larynx. TORS offers several advantages, including improved visualisation for the surgeon, greater precision, faster recovery times, and the potential to avoid more invasive open procedures or extensive radiotherapy.
Our trans-nasal oesophagoscopy (TNO) service is one of the busiest in East of England. TNO is a minimally invasive procedure that allows direct examination of the upper aero-digestive tract (including the throat, voice box, gullet and stomach) using a slim, flexible endoscope passed through the nose. Unlike traditional endoscopy, TNO is performed under local anaesthetic, avoiding the need for sedation or general anaesthesia and a theatre slot. We offer LASER ablation of lesions through the scope when appropriate, at the same setting.
We also offer a dedicated voice clinic for patients with voice disorders, supported by specialist speech and swallow therapists. Patients undergoing treatment for head and neck cancer have access to a comprehensive support team, including a dedicated dietitian, to help maintain nutrition and quality of life before, during, and after treatment.
Our service is part of the wider East and North Hertfordshire NHS Trust, which includes Mount Vernon Cancer Centre – one of the largest and most respected cancer centres in the UK – further enhancing the scope and depth of cancer care we provide.
Research and education are integral to our work. Our team contributes to ongoing clinical research and regularly presents at national and international meetings. A list of our recent publications and presentations is available below.
Referrals can be made via the NHS e-Referral Service (ERS) or by contacting the ENT department directly. GPs and other healthcare professionals are welcome to discuss cases with our consultants prior to referral for guidance.
ENT Department – Lister Hospital
East and North Hertfordshire NHS Trust
Coreys Mill Lane, Stevenage, Hertfordshire SG1 4AB
Tel: 01438 314333 (Switchboard)
Email: [email protected]
Kaleva A, Patel A, Sooriyamoorthy T, Dimitriadis PA, Rajaguru K, Mochloulis G. Utility of intra-operative ultrasound in revision neck dissection for loco-regional thyroid cancer recurrence. Clinical Otolaryngology. March 2024, doi: 10.1111/coa.14153. Online ahead of print.
Locatello L, Costandino A, Maniaci A, Fermi M, Barillari M, Sampieri C, Bellini E, Serafini E, Jiang S, Nocera F, Asaro A, Midolo M, Rodio A, Piersiala K, Sooriyamoorthy T, Dimitriadis PA, Mannelli G. Does Sex influence the prognosis of laryngeal cancer? A systematic review and a Meta-analysis. American Journal of Otolaryngology, December 2023, 15;45(2):104195, PMID: 38134851
Dimitriadis PA, Moinie A, Michaels J, Bance R, Vijendren A, Mochloulis G. Indeterminate Thyroid Nodules (Thy3): Malignancy rate and characteristics in a study of 118 patients. Annals of Royal College of Surgeons, 2023; Jul; 105(6): 568-571, PMID: 36927065
Wakeford W, Tzortzis A, Galan C, Kwatra D, Patel A, Dimitriadis PA, Mochloulis G. A First UK Single Centre Experience of Robotic Facelift Thyroidectomy. Poster presentation, World Congress thyroid Cancer, London, Boston 2025
Galan C, Kwatra D, Dimitriadis P, Karamitsou P, Vijendren A, Patel A, Rajaguru K, Mochloulis G. Efficacy and Safety of RFA for metastatic thyroid carcinoma to the lateral neck: A review of the literature. Oral presentation, World Congress thyroid Cancer, Boston, July 2025
Galan C, Kwatra D, Dimitriadis P, Vijendren A, Patel A, Rajaguru K, Mochloulis G. How to establish a surgically-led Thyroid Radiofrequency Ablation service in the UK. Poster presentation, World Congress thyroid Cancer, Boston, July 2025
Karamitsou P, Galan C, Patel A, Vijendren A, Mochloulis G, Dimitriadis P. Risk of malignancy in Thy3 thyroid nodules: our experience with 136 consecutive patients. Oral presentation, World Congress thyroid Cancer, Boston, July 2025
Jalalimehr R, Galan C, Kwatra D, Patel A, Senbeto M, Balasubramanian S, Dimitriadis PA, Mochloulis G. Inadvertent Parathyroidectomy in Thyroid Surgery with and Without Fluorescent Imaging: A Multi-centre analysis. Oral presentation, World Congress thyroid Cancer, Boston, July 2025
Dimitriadis PA. Non-surgical management of Thyroid nodules. Oral presentation at Endocrine surgery Bootcamp. 44th Annual Scientific Meeting BAETS, October 2024, London
Galan C, Dimitriadis PA, Patel A, Mochloulis G. How to establish a surgically-led Radiofrequency Ablation (RFA) thyroid ablation service in the UK. Oral presentation, 44th Annual Scientific Meeting BAETS, October 2024, London
Elsanousi S, Dimitriadis PA, Patel A, Langroudi B, George S, Zalin B, Mohamed S, Yasin Z, Naraynswamy S, Kaplan F, Filipas E, Alsabbagh S, Joharatnam J, Winocour P, Mochloulis G, Zac-Varghese S. Audit into pre-operative workup, surgery and outcomes for primary hyperparathyroidism. Poster presentation, 44th Annual Scientific Meeting BAETS, October 2024, London
Dimitriadis PA. Indeterminate Thyroid Cytology: Malignancy rates and future prospects. Oral presentation, 6th Congress of European ORL-Head & Neck Surgery, Dublin, June 2024
Tadrous A, Go G, Fernandes M, Secondes B, Patel A, Mochloulis G, Vijendren A, Dimitriadis PA. Transnasal oesophagoscopy: Patients’ satisfaction scores. Poster presentation, 6th Congress of European ORL-Head & Neck Surgery, Dublin, June 2024
Sherwani I, Patel A, Vijendren A, Dimitriadis PA, Mochloulis G. Continuous Intra-operative Nerve Monitoring in Thyroid Surgery: Amplitude, as an indicator of post-operative vocal cord palsy- A case-controlled study. Poster presentation, 6th Congress of European ORL-Head & Neck Surgery, Dublin, June 2024
Tadrous A, Go G, Fernandez M, Secondes B, Patel A, Mochloulis G, Dimitriadis PA, Vijendren A. Transnasal oesophagoscopy: Outcomes from the first 150 procedures and financial implications. Oral presentation, 6th Congress of European ORL-Head & Neck Surgery, Dublin, June 2024
Consultants with specialist interest in Thyroid, Parathyroid and Head and Neck Surgery
- Mr. George Mochloulis
- Mr. Panos Dimitriadis
- Mr. Anant Patel
